Association of a HOXB13 variant with breast cancer.
作者信息
Alanee Shaheen, Couch Fergus, Offit Kenneth
出版信息
N Engl J Med. 2012 Aug 2;367(5):480-1. doi: 10.1056/NEJMc1205138.
Abstract
摘要
相似文献
1
Association of a HOXB13 variant with breast cancer.HOXB13基因变异与乳腺癌的关联。
N Engl J Med. 2012 Aug 2;367(5):480-1. doi: 10.1056/NEJMc1205138.
2
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.HOXB13 p.Gly84Glu 突变与乳腺癌风险无关。
Breast Cancer Res Treat. 2012 Dec;136(3):907-9. doi: 10.1007/s10549-012-2295-y. Epub 2012 Oct 26.
3
Mutation HOXB13 c.853delT in Martinican prostate cancer patients.在法属马丁尼克岛的前列腺癌患者中发现 HOXB13 c.853delT 突变。
Prostate. 2020 May;80(6):463-470. doi: 10.1002/pros.23960. Epub 2020 Feb 10.
4
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.细胞色素P450 2D6与同源盒13/白细胞介素-17B受体：联合遗传性和肿瘤基因标志物预测他莫昔芬耐药性
Clin Cancer Res. 2008 Sep 15;14(18):5864-8. doi: 10.1158/1078-0432.CCR-08-0619.
5
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.荷兰人群中HOXB13基因的复发性突变与乳腺癌风险增加无关。
Sci Rep. 2016 Jul 18;6:30026. doi: 10.1038/srep30026.
6
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.探索乳腺癌中的双基因比例——HOXB13和IL17BR在临床结果预测中的独立作用。
Breast Cancer Res Treat. 2008 Jan;107(2):225-34. doi: 10.1007/s10549-007-9541-8. Epub 2007 Apr 24.
7
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.芬兰 HOXB13 G84E 突变：前列腺癌、乳腺癌和结直肠癌风险的基于人群的分析。
Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):452-60. doi: 10.1158/1055-9965.EPI-12-1000-T. Epub 2013 Jan 4.
8
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.HOXB13与IL17BR表达比值与复发性乳腺癌的肿瘤侵袭性及他莫昔芬反应相关：一项回顾性研究
J Clin Oncol. 2007 Feb 20;25(6):662-8. doi: 10.1200/JCO.2006.07.3676.
9
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.用于预测接受他莫昔芬辅助治疗的女性复发和生存情况的同源盒13与白细胞介素-17B受体的双基因表达比值
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7. doi: 10.1158/1078-0432.CCR-05-1263.
10
Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.雌激素调节的同源框B13基因在乳腺癌中的表观遗传抑制
Carcinogenesis. 2008 Jul;29(7):1459-65. doi: 10.1093/carcin/bgn115. Epub 2008 May 21.
引用本文的文献
1
HOXB13 in cancer development: molecular mechanisms and clinical implications.HOXB13在癌症发展中的作用：分子机制与临床意义
Front Med. 2025 Mar 11. doi: 10.1007/s11684-024-1119-x.
2
Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4.人表皮生长因子受体2（Her2）通过下调丝裂原活化蛋白激酶激酶激酶4（MAP3K4）抑制p38信号通路，从而促进乳腺癌的早期扩散。
Cell Commun Signal. 2024 Dec 19;22(1):611. doi: 10.1186/s12964-024-02000-2.
3
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.胚系 HOXB13 突变 p.G84E 和 p.R217C 不会增加乳腺癌风险。
Sci Rep. 2020 Jun 16;10(1):9688. doi: 10.1038/s41598-020-65665-y.
4
The Role of HOX Transcription Factors in Cancer Predisposition and Progression.HOX转录因子在癌症易感性和进展中的作用。
Cancers (Basel). 2019 Apr 12;11(4):528. doi: 10.3390/cancers11040528.
5
The Enigmatic HOX Genes: Can We Crack Their Code?神秘的HOX基因：我们能破解它们的密码吗？
Cancers (Basel). 2019 Mar 7;11(3):323. doi: 10.3390/cancers11030323.
6
Role of HOX Genes in Stem Cell Differentiation and Cancer.HOX基因在干细胞分化和癌症中的作用。
Stem Cells Int. 2018 Jul 22;2018:3569493. doi: 10.1155/2018/3569493. eCollection 2018.
7
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.一种复发性ERCC3截短突变赋予乳腺癌中度风险。
Cancer Discov. 2016 Nov;6(11):1267-1275. doi: 10.1158/2159-8290.CD-16-0487. Epub 2016 Sep 21.
8
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.荷兰人群中HOXB13基因的复发性突变与乳腺癌风险增加无关。
Sci Rep. 2016 Jul 18;6:30026. doi: 10.1038/srep30026.
9
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.基于美国医学遗传学与基因组学学会（ACMG）指南对乳腺癌家族中癌症易感性基因和非癌症相关基因变异分类的评估
Am J Hum Genet. 2016 May 5;98(5):801-817. doi: 10.1016/j.ajhg.2016.02.024.
10
HOX genes: Major actors in resistance to selective endocrine response modifiers.HOX基因：对选择性内分泌反应调节剂产生抗性的主要因素。
Biochim Biophys Acta. 2016 Apr;1865(2):105-10. doi: 10.1016/j.bbcan.2016.01.003. Epub 2016 Jan 22.
本文引用的文献
1
Germline mutations in HOXB13 and prostate-cancer risk.HOXB13 种系突变与前列腺癌风险。
N Engl J Med. 2012 Jan 12;366(2):141-9. doi: 10.1056/NEJMoa1110000.
2
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.HOXB13 蛋白表达对乳腺癌他莫昔芬获益的预测相关性。
Breast Cancer Res. 2010;12(4):R53. doi: 10.1186/bcr2612. Epub 2010 Jul 22.
3
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.双基因表达比率可预测接受他莫昔芬治疗的乳腺癌患者的临床结局。
Cancer Cell. 2004 Jun;5(6):607-16. doi: 10.1016/j.ccr.2004.05.015.
4
In vivo expression of the whole HOX gene network in human breast cancer.人乳腺癌中整个HOX基因网络的体内表达
Eur J Cancer. 2003 Jan;39(2):257-64. doi: 10.1016/s0959-8049(02)00599-3.
Zotero 插件